DICE Therapeutics, Inc. (DICE): Price and Financial Metrics

DICE Therapeutics, Inc. (DICE): $47.55

0.03 (+0.06%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add DICE to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#364 of 387

in industry

DICE Price/Volume Stats

Current price $47.55 52-week high $47.90
Prev. close $47.52 52-week low $15.08
Day low $47.46 Volume 4,332,900
Day high $47.83 Avg. volume 1,028,719
50-day MA $42.55 Dividend yield N/A
200-day MA $34.31 Market Cap 2.27B

DICE Stock Price Chart Interactive Chart >


DICE Therapeutics, Inc. (DICE) Company Bio


DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is S011806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2013 and is headquartered in South San Francisco, California.


DICE Latest News Stream


Event/Time News Detail
Loading, please wait...

DICE Latest Social Stream


Loading social stream, please wait...

View Full DICE Social Stream

DICE Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!